Cardiovascular disease is the leading cause of death globally. While CT scans are essential for detecting coronary artery disease, they remain time-consuming and require highly specialized expertise. There is an urgent need for fast, accurate, cost-efficient CT solutions to identify, stage and monitor coronary artery disease, especially in the underserved ASEAN region. 

THEIA Health Pte Ltd leverages proprietary deep learning algorithms and medical image post-processing technology to automate centerline detection, auto-labelling, 3D segmentation and coronary artery reconstruction. This technology is built on exclusive IP from the founders’ research backed by $7M grant funding and a unique dataset comprising over 5000-patients and 3 million images. It enables doctors to quickly analyze calcium score, epicardial adipose tissue, coronary artery stenosis and plaque characteristics and coronary flow index, producing reports in less than 6 minutes. This enhances diagnostic workflows and supports rapid coronary CTA assessment.  

This product is adaptable for seamless integration into various clinical workflows, meeting the diverse needs of the ASEAN healthcare market. This product serves as an objective, quantitative tool for day-to-day usage in clinical and research settings.